Katapult Holdings, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K, dated June 12, 2025, details a material definitive agreement entered into by Katapult Holdings, Inc. (the "Company") and its subsidiaries. The filing discloses the execution of an Amended and Restated Loan and Security Agreement (the "Refinancing Agreement") and the issuance of warrants to certain entities affiliated with Blue Owl Capital Inc.
Key Financial Metrics and Debt Structure
The filing outlines a significant restructuring of the Company's debt facilities:
- New Revolving Facility: An upsized committed amount of $110,000,000. This includes a continuation of existing advances and $20,000,000 in new commitments. Borrowing capacity is subject to an advance rate of 91.00% (increasing to 99.00% by November 1, 2025) on eligible lease collateral.
- New Term Loan: An initial principal amount of $32,654,469.23, representing a cashless conversion of existing term loans. The loan does not amortize.
- Interest Rates:
- Revolving Facility: Term SOFR + 7.00% (subject to a 3% floor and 0.10% credit adjustment).
- Term Loan: 18.00% per annum, accruing as paid-in-kind (PIK) interest weekly.
- Warrants Issued: Warrants to purchase up to 486,264 shares of Common Stock at an exercise price of $0.01 per share. These expire on June 12, 2032.
The filing does not provide specific revenue, profit, cash flow, or liquidity metrics for the reporting period, as this is a transactional filing rather than a periodic financial report.
Material Changes and Conditions
The Refinancing Agreement amends and restates the Existing Credit Agreement dated May 14, 2019. Key changes include:
- Upsizing: The revolving facility was increased by $20,000,000.
- Default Waiver: Lenders waived certain Existing Defaults existing as of the closing date, contingent upon the receipt of Requisite Stockholder Approval by September 1, 2025.
- Conversion Rights: Class B Lenders holding 51% of the New Term Loans may force conversion of the loan into Common Stock (plus cash for fractions) after 12 months from stockholder approval, after June 30, 2026, or upon an Event of Default. The conversion price is the greater of $2.00 or a 50% discount to the 20-day VWAP (with discounts reducing as stock price rises above $10.00).
- Maturity Dates: The Term Loan matures on the earlier of December 4, 2026, or September 1, 2025 (if stockholder approval is not obtained).
Outlook, Risks, and Management Commentary
Management intends to pursue strategic alternatives to repay the Term Loan, including refinancing, equity capital raises, or a sale of the business, though no assurances are provided. The transaction is subject to significant risks:
- Stockholder Approval: The waiver of defaults and the full terms of the agreement are contingent on Requisite Stockholder Approval by September 1, 2025. Failure to obtain this approval could trigger an earlier maturity date for the Term Loan.
- Dilution: The issuance of Warrants and potential conversion of the Term Loan into equity will result in significant dilution to existing shareholders.
- Covenants: The agreement imposes strict financial covenants, including Minimum Trailing Three-Month Net Origination levels and Minimum Liquidity requirements. Negative covenants restrict dividends, additional indebtedness, and asset sales.
- Forward-Looking Statements: The Company disclaims any obligation to update forward-looking statements regarding the ability to complete the transaction or obtain necessary approvals.
Key Facts for Investor Verification
- Verify the status of the "Requisite Stockholder Approval" required by September 1, 2025, to avoid an immediate maturity of the Term Loan.
- Review the upcoming proxy statement for details on the equity issuance and voting procedures.
- Assess the impact of the 18% PIK interest rate on the Company's effective debt burden and future cash flow requirements.
- Monitor the Company's ability to meet the Minimum Trailing Three-Month Net Origination and Minimum Liquidity covenants.
- Examine the potential dilution from the 486,264 warrants issued at $0.01 and the potential conversion of the $32.65 million Term Loan.